Pitts called the original bad ad Program "a complete waste of time," maintaining that FDA never really determined what was a bad ad, and that FDA should instead be focusing on regulating safety and efficacy. "FDA does not regulate creativity," Pitts added.
This post first appeared on Drugwonks | Welcome To The New Drugwonks.com, please read the originial post: here
